Physician profile
David J Kushner
NPI 1053341487
$39,207.51
in general payments reported to CMS, 2019-2025
10 companies · $23K in 2025
The $23K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $62.13 · 2021: $63.28 · 2022: $3,201 · 2023: $271 · 2024: $13K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $22K · Travel and Lodging: $6,030 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,336 · Food and Beverage: $1,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $22,400.00 |
| Travel and Lodging | $6,030.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,336.00 |
| Food and Beverage | $1,891.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $29,582.80 | 2023-2025 | Brixadi |
| Indivior INC. | $5,987.76 | 2019-2025 | Sublocade |
| Gilead Sciences, INC. | $2,986.94 | 2019-2022 | |
| Uswm, LLC | $240.20 | 2021-2024 | Lucemyra, Zimhi |
| Orexo US, INC. | $163.40 | 2019-2025 | Zubsolv |
| Mdd US Operations, LLC | $115.76 | 2019 | |
| Hikma Pharmaceuticals USA | $59.22 | 2022 | |
| Pear Therapeutics (US), INC. | $40.63 | 2022 | |
| Melinta Therapeutics, LLC | $19.50 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kushner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.